Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.santini@uniroma1.it
Daniele Santini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
daniele.santini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Epidemiologia e caratteristiche delle metastasi ossee
Manuale di oncologia medica
2018
Epidemiologia e caratteristiche delle metastasi ossee
Manuale di oncologia medica
2018
Bone Health in Cancer Patients
Practical Medical Oncology Textbook
2018
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer
Dammacco: Oncogenomics
2018
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma
JOURNAL OF CLINICAL ONCOLOGY
2018
Bone Health in Cancer Patients
Practical Medical Oncology Textbook
2018
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer
Dammacco: Oncogenomics
2018
The use of SAMe in chemotherapy-induced liver injury
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2018
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
2018
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol
TUMORI
2018
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2018
Efficacy of anti-EGFR rechallenge in RAS and BRAF wt metastatic colorectal cancer: Clinical and translational results of the phase II CRICKET study by GONO
CANCER RESEARCH
2018
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2018
Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial
ANNALS OF ONCOLOGY
2018
FAP-related desmoid tumours treated with low dose chemotherapy: results from a multicentre retrospective analysis
JOURNAL OF CLINICAL ONCOLOGY
2018
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment
SCIENTIFIC REPORTS
2018
RANK expression in circulating tumor cells (CTCs): clinical utility in monitoring metastatic breast cancer patients (MBC) under denosumab treatment
CLINICAL & EXPERIMENTAL METASTASIS
2018
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma
ANTI-CANCER DRUGS
2018
Breakthrough cancer pain (BTcP) management: a review of international and national guidelines
BMJ SUPPORTIVE & PALLIATIVE CARE
2018
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram
ONCOLOGY
2018
« prima
< precedente
…
6
7
8
9
10
11
12
13
14
15
16
17
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma